<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="73752">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01740843</url>
  </required_header>
  <id_info>
    <org_study_id>MECU2012-004</org_study_id>
    <nct_id>NCT01740843</nct_id>
  </id_info>
  <brief_title>The Effect of tDCS on Motor Performance and Cortical Excitability</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hasselt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hasselt University</source>
  <oversight_info>
    <authority>Belgium: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study the effect of tDCS intensity on motor performance and corticospinal (CS)
      excitability is evaluated. The investigators expect that a positive relationship between
      current intensity and motor performance/CS excitability.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in motor performance</measure>
    <time_frame>Baseline and POST (30 min after baseline) intervention</time_frame>
    <safety_issue>No</safety_issue>
    <description>motor performance is assessed using different reaction time paradigms (simple reaction time, choice reaction time). This is done at baseline and immediately after the intervention (30 min after baseline)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in cortical excitability</measure>
    <time_frame>Baseline and POST (30 min after baseline) intervention</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Cortical excitability is measured using trancranial magnetic stimulation (TMS) measuring muscle evoked potentials (MEPs) at baseline and POST (30 min after baseline).</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Cortical Excitability</condition>
  <condition>Motor Performance</condition>
  <condition>tDCS</condition>
  <arm_group>
    <arm_group_label>Low intensity anodal tDCS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>tDCS will be administered for 10 min at 1mA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High intensity anodal tDCS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>tDCS will be administered for 10 min at 2.5mA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham tDCS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham will be administered for 10 min at 0 mA</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcranial direct current stimulation (tDCS) (NeuroConn DC-stimulator)</intervention_name>
    <description>The anode is fixed on the primary cortex and the cathode will be fixed on the contralateral supraorbital region.</description>
    <arm_group_label>Low intensity anodal tDCS</arm_group_label>
    <arm_group_label>High intensity anodal tDCS</arm_group_label>
    <arm_group_label>Sham tDCS</arm_group_label>
    <other_name>NeuroConn DC-stimulator</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Healthy subjects

        Exclusion Criteria:

          -  Contraindications for tDCS/TMS

          -  TMS measurements have to be possible
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 24, 2014</lastchanged_date>
  <firstreceived_date>November 26, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hasselt University</investigator_affiliation>
    <investigator_full_name>Koen Cuypers</investigator_full_name>
    <investigator_title>Drs. Koen Cuypers</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
